Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
Abstract Hepatocyte growth factor and its receptor cMet activate biological pathways necessary for repair and regeneration following kidney injury. Here, we evaluated the clinical role of urinary cMet as a prognostic biomarker in diabetic nephropathy (DN). A total of 218 patients with DN were enroll...
Guardado en:
Autores principales: | Yong Chul Kim, Jung Nam An, Jin Hyuk Kim, Young-Wook Choi, Sohee Oh, Sang Ho Kwon, Mi-Young Lee, Junghun Lee, Jae-Gyun Jeong, Chun Soo Lim, Yon Su Kim, Seung Hee Yang, Jung Pyo Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/00399e8fbf4e4a6fbd44b1b1795bdc1f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma
por: Birgit Lohberger, et al.
Publicado: (2021) -
EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming
por: Fanyan Meng, et al.
Publicado: (2019) -
Low serum total CO2 and its association with mortality in patients being followed up in the nephrology outpatients clinic
por: Kyung Don Yoo, et al.
Publicado: (2021) -
Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites.
por: Jin Wook Lee, et al.
Publicado: (2021) -
Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer
por: Jae-Hoon Lee, et al.
Publicado: (2021)